ELK3 suppresses angiogenesis by inhibiting the transcriptional activity of ETS-1 on MT1-MMP

International Journal of Biological Sciences

Volumn 10, Issue 4, 2014, Pages 438-447

  Heo, Sun Hee ^a   Cho, Je Yoel ^a  

^a Seoul National University   (South Korea)

Author keywords

ELK3; MT1 MMP; Sin3A; VEGF

Indexed keywords

ELK3 PROTEIN, HUMAN; ETS1 PROTEIN, HUMAN; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; MMP14 PROTEIN, HUMAN; ONCOPROTEIN; REPRESSOR PROTEIN; SIN3A TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS 1; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; BAGG ALBINO MOUSE; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; MALE; METABOLISM; MOUSE; PHYSIOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; MALE; MATRIX METALLOPROTEINASE 14; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84897050071     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.8095     Document Type: Article

References (35)

1. Folkman J. Angiogenesis. Annual review of medicine. 2006; 57: 1-18.
2. Carmeliet P. Angiogenesis in health and disease. Nature medicine. 2003; 9: 653-60.
3. Jain RK. Molecular regulation of vessel maturation. Nature medicine. 2003; 9: 685-93.
4. Sato Y. Role of ETS family transcription factors in vascular development and angiogenesis. Cell structure and function. 2001; 26: 19-24.
5. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nature reviews. 2003; 3: 401-10.
6. Sementchenko VI, Watson DK. Ets target genes: past, present and future. Oncogene. 2000; 19: 6533-48.
7. Sharrocks AD. The ETS-domain transcription factor family. Nat Rev Mol Cell Biol. 2001; 2: 827-37.
8. Karim FD, Urness LD, Thummel CS, Klemsz MJ, McKercher SR, Celada A, et al. The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence. Genes & development. 1990; 4: 1451-3.
9. Nye JA, Petersen JM, Gunther CV, Jonsen MD, Graves BJ. Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif. Genes & development. 1992; 6: 975-90.
10. Heo SH, Choi YJ, Ryoo HM, Cho JY. Expression profiling of ETS and MMP factors in VEGF-activated endothelial cells: role of MMP-10 in VEGF-induced angiogenesis. Journal of cellular physiology. 2010;224: 734-42.
11. Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nature reviews. 2002; 2: 657-72.
12. Rundhaug JE. Matrix metalloproteinases and angiogenesis. Journal of cellular and molecular medicine. 2005; 9: 267-85.
13. Randi AM, Sperone A, Dryden NH, Birdsey GM. Regulation of angiogenesis by ETS transcription factors. Biochemical Society transactions. 2009; 37: 1248-53.
14. Kita D, Takino T, Nakada M, Takahashi T, Yamashita J, Sato H. Expression of dominant-negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin alpha5 expression in U251 glioma cell line. Cancer research. 2001; 61: 7985-91.
15. Spyropoulos DD, Pharr PN, Lavenburg KR, Jackers P, Papas TS, Ogawa M, et al. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Molecular and cellular biology. 2000; 20: 5643-52.
16. Wang LC, Kuo F, Fujiwara Y, Gilliland DG, Golub TR, Orkin SH. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. The EMBO journal. 1997; 16: 4374-83.
17. Wang LC, Swat W, Fujiwara Y, Davidson L, Visvader J, Kuo F, et al. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes & development. 1998; 12: 2392-402.
18. Giovane A, Pintzas A, Maira SM, Sobieszczuk P, Wasylyk B. Net, a new ets transcription factor that is activated by Ras. Genes & development. 1994; 8: 1502-13.
19. Ayadi A, Suelves M, Dolle P, Wasylyk B. Net, an Ets ternary complex transcription factor, is expressed in sites of vasculogenesis, angiogenesis, and chondrogenesis during mouse development. Mechanisms of development. 2001; 102: 205-8.
20. Giovane A, Sobieszczuk P, Mignon C, Mattei MG, Wasylyk B. Locations of the ets subfamily members net, elk1, and sap1 (ELK3, ELK1, and ELK4) on three homologous regions of the mouse and human genomes. Genomics. 1995; 29: 769-72.
21. Zheng H, Wasylyk C, Ayadi A, Abecassis J, Schalken JA, Rogatsch H, et al. The transcription factor Net regulates the angiogenic switch. Genes & development. 2003; 17: 2283-97.
22. Hollenhorst PC, Jones DA, Graves BJ. Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic acids research. 2004; 32: 5693-702.
23. Ayadi A, Zheng H, Sobieszczuk P, Buchwalter G, Moerman P, Alitalo K, et al. Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1. The EMBO journal. 2001; 20: 5139-52.
24. Nagase H, Woessner JF, Jr. Matrix metalloproteinases. The Journal of biological chemistry. 1999; 274: 21491-4.
25. Itoh Y, Seiki M. MT1-MMP: an enzyme with multidimensional regulation. Trends in biochemical sciences. 2004; 29: 285-9.
26. Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer letters. 2003; 194: 1-11.
27. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell. 2003; 114: 33-45.
28. Ducret C, Maira SM, Lutz Y, Wasylyk B. The ternary complex factor Net contains two distinct elements that mediate different responses to MAP kinase signalling cascades. Oncogene. 2000; 19: 5063-72.
29. Maira SM, Wurtz JM, Wasylyk B. Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif. The EMBO journal. 1996; 15: 5849-65.
30. Wasylyk C, Zheng H, Castell C, Debussche L, Multon MC, Wasylyk B. Inhibition of the Ras-Net (Elk-3) pathway by a novel pyrazole that affects microtu-bules. Cancer research. 2008; 68: 1275-83.
31. Wasylyk C, Criqui-Filipe P, Wasylyk B. Sumoylation of the net inhibitory domain (NID) is stimulated by PIAS1 and has a negative effect on the tran-scriptional activity of Net. Oncogene. 2005; 24: 820-8.
32. Buchwalter G, Gross C, Wasylyk B. The ternary complex factor Net regulates cell migration through inhibition of PAI-1 expression. Molecular and cellular biology. 2005; 25: 10853-62.
33. Gross C, Dubois-Pot H, Wasylyk B. The ternary complex factor Net/Elk-3 participates in the transcriptional response to hypoxia and regulates HIF-1 alpha. Oncogene. 2008; 27: 1333-41.
34. Sugimoto H, Okamura K, Sugimoto S, Satou M, Hattori T, Vance DE, et al. Sp1 is a co-activator with Ets-1, and Net is an important repressor of the transcription of CTP:phosphocholine cytidylyltransferase alpha. The Journal of biological chemistry. 2005; 280: 40857-66. doi:10.1074/jbc.M503578200.
35. Criqui-Filipe P, Ducret C, Maira SM, Wasylyk B. Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. The EMBO journal. 1999; 18: 3392-403.